Holen Sie sich die Stockscreener-App
373.36
1.13%
4.17
Vorhandelsmarkt:
373.80
0.44
+0.12%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Piper Sandler raises Amgen stock price target on drug pipeline - Investing.com
Amgen Stock Is Up 14% This Year on Dual Drug Approvals. Can the Rally Hold? - TIKR.com
First National Bank of Omaha Purchases Shares of 40,836 Amgen Inc. $AMGN - MarketBeat
Crestwood Advisors Group LLC Boosts Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc Files For Four-Part Senior Notes Offering Of Up To $4 Bln - TradingView
Amgen’s Uplizna now approved in EU to treat most adults with gMG - Myasthenia Gravis News
NEOS Investment Management LLC Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
Skandinaviska Enskilda Banken AB publ Lowers Stake in Amgen Inc. $AMGN - MarketBeat
Zions Bancorporation National Association UT Sells 10,088 Shares of Amgen Inc. $AMGN - MarketBeat
Vanguard Group Inc. Purchases 165,281 Shares of Amgen Inc. $AMGN - MarketBeat
Public Sector Pension Investment Board Has $13.34 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Holdings Lowered by Fifth Third Bancorp - MarketBeat
Amgen Inc. (AMGN) Stock Analysis: Evaluating the Performance and Growth Potential of a Biotech Giant - DirectorsTalk Interviews
Amgen Inc (AMGN) Stock Price, Trades & News - GuruFocus
Why Amgen Inc. stock is seen as undervaluedWeekly Profit Analysis & Safe Capital Growth Tips - mfd.ru
Shell Asset Management Co. Has $2.82 Million Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by State of New Jersey Common Pension Fund D - MarketBeat
A Look At Amgen (AMGN) Valuation After Strong Q4 Results And New UPLIZNA Approval - simplywall.st
PNC Financial Services Group Inc. Increases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
HighTower Advisors LLC Grows Position in Amgen Inc. $AMGN - MarketBeat
ABN Amro Investment Solutions Sells 8,219 Shares of Amgen Inc. $AMGN - MarketBeat
Aberdeen Group plc Sells 76,076 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Downgraded to "Hold" Rating by Freedom Capital - MarketBeat
BTC Capital Management Inc. Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Assetmark Inc. Buys 10,886 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Position Lifted by Ameritas Advisory Services LLC - MarketBeat
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight - GuruFocus
Amgen (AMGN) Files for Automatic Mixed Securities Shelf Registra - GuruFocus
AMGEN INC SEC 10-K Report - TradingView
AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT - marketscreener.com
Here's What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN) - Bitget
Amgen wins new European approval for Uplizna in generalised myasthenia gravis - European Pharmaceutical Review
Here’s what Argus Research and Guggenheim are saying about Amgen Inc. (AMGN) - MSN
Here’s What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN) - Yahoo Finance
Amgen wins European approval to challenge argenx and UCB for autoimmune market - European Biotechnology Magazine
Amgen Inc. $AMGN Shares Sold by Savvy Advisors Inc. - MarketBeat
LSV Asset Management Raises Holdings in Amgen Inc. $AMGN - MarketBeat
Krilogy Financial LLC Takes $1.25 Million Position in Amgen Inc. $AMGN - MarketBeat
Baader Bank Aktiengesellschaft Lowers Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stake Lessened by Atria Investments Inc - MarketBeat
UPLIZNA’s Expanded EU Use in Autoimmune Disease Could Be A Game Changer For Amgen (AMGN) - simplywall.st
Amgen Conference: UPLIZNA Phase III Plans, Daxdilimab Lupus Data, and TEZSPIRE Expansion Update - MarketBeat
AMGN: Advancing late-stage trials and expanding TSLP-targeted therapies, with major data readouts ahead - TradingView
Traders Buy Large Volume of Amgen Call Options (NASDAQ:AMGN) - MarketBeat
Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.52 - Yahoo Finance
Amgen wins EC approval for Uplizna in gMG - The Pharma Letter
Amgen wins EC approval for Uplinza in gMG - The Pharma Letter
Can Amgen Inc. reach all time highs this yearQuarterly Profit Summary & Long-Term Growth Portfolio Plans - mfd.ru
Varma Mutual Pension Insurance Co Buys 7,300 Shares of Amgen Inc. $AMGN - MarketBeat
EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS - PR Newswire
Leuthold Group LLC Purchases New Stake in Amgen Inc. $AMGN - MarketBeat
Stratos Wealth Partners LTD. Has $8.83 Million Stake in Amgen Inc. $AMGN - MarketBeat
Cibc World Market Inc. Grows Stake in Amgen Inc. $AMGN - MarketBeat
ABC Arbitrage SA Cuts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Ex-Dividend Reminder: Cencora, Amgen and Oppenheimer Holdings - Nasdaq
Amgen (AMGN) is a Top-Ranked Momentum Stock: Should You Buy? - Yahoo Finance
Amgen (NASDAQ:AMGN) Price Target Raised to $295.00 - MarketBeat
Rhumbline Advisers Sells 6,685 Shares of Amgen Inc. $AMGN - MarketBeat
Prospera Financial Services Inc Sells 6,723 Shares of Amgen Inc. $AMGN - MarketBeat
Caprock Group LLC Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Wealthfront Advisers LLC Grows Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Holdings Reduced by Allegheny Financial Group - MarketBeat
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - Stock Traders Daily
AstraZeneca Unit Settles Soliris Feud With Samsung, Amgen - Law360
Mizuho Raises Price Target on Amgen to $295 From $280, Keeps Outperform Rating - marketscreener.com
Daiwa Securities Group Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat
Just Two Days Till Amgen Inc. (NASDAQ:AMGN) Will Be Trading Ex-Dividend - 富途牛牛
United States Biotechnology Market to hit US$ 1.5 Trillion - openPR.com
Two Days Left Until Amgen Inc. (NASDAQ:AMGN) Trades Ex-Dividend - simplywall.st
0.19%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):